DarioHealth announces publication of study in JMIR on digital health platform

DarioHealth (DRIO) announced the publication of a new peer-reviewed study in the Journal of Medical Internet Research, JMIR, evaluating healthcare utilization and medical costs among Dario users compared to matched non-users receiving usual care. The study, “Effects of a Digital Health Intervention for Adults with Type 2 Diabetes Mellitus on Health Care Resource Use and Health Care Charges in the United States: Retrospective Cohort Study,” was not authored by Dario, but rather conducted by researchers at Sanofi (SNY) and Symphony Health. Across multiple measures of healthcare utilization, charges and estimated costs, Dario users demonstrated consistently lower burden compared to a matched group receiving usual care: 23.5% lower inpatient hospitalization rates; 9.3% lower all-cause healthcare resource utilization; 26% lower all-cause HCRU charges; Estimated gross cost savings of $5,077 per patient per year based on standard cost-to-charge conversion methodologies; Shorter inpatient lengths of stay; Lower 30-day readmission rates; A strong dose-response relationship, with more frequent engagement on the Dario platform associated with fewer inpatient and ER events